From Casetext: Smarter Legal Research

McDonald v. Am. Med. Sys.

United States District Court, Central District of California
Mar 22, 2022
2:21-cv-09649-MCS-PD (C.D. Cal. Mar. 22, 2022)

Opinion

2:21-cv-09649-MCS-PD

03-22-2022

AUDRA MCDONALD, Plaintiff, v. AMERICAN MEDICAL SYSTEMS, INC.; and DOES 1-10, inclusive, Defendants.

David E. Stanley Jonathan Barrera REED SMITH LLP Attorneys for Defendant Astora Women's Health, LLC (f/k/a American Medical Systems, Inc.). Nathan W. Fransen, Paul J. Molinaro, FRANSEN & MOLINARO, LLP Brittany A. Rygiel MOLL LAW GROUP Attorneys for Plaintiff Audra McDonald.


Honorable Mark C. Scarsi, Judge.

David E. Stanley Jonathan Barrera REED SMITH LLP Attorneys for Defendant Astora Women's Health, LLC (f/k/a American Medical Systems, Inc.).

Nathan W. Fransen, Paul J. Molinaro, FRANSEN & MOLINARO, LLP Brittany A. Rygiel MOLL LAW GROUP Attorneys for Plaintiff Audra McDonald.

DISCOVERY MATTER CONFIDENTIALITY AND PROTECTIVE ORDER

Honorable Patricia Donahue, Judge.

WHEREAS Plaintiff Audra McDonald (“Plaintiff”), and Defendant Astora Women's Health, LLC (f/k/a American Medical Systems, Inc.) (“Defendant”), jointly believe that entry of a protective order pursuant to Federal Rule of Civil Procedure 26(c) should be applied to this matter;

WHEREAS, a protective order will expedite the flow of discovery material, facilitate the prompt resolution of disputes over confidentiality, and adequately protect confidential material;

NOW, THEREFORE, having found good cause, it is hereby ORDERED THAT:

I. Purposes and Limitations

Disclosure and discovery in this proceeding may involve production of information and/or materials which are claimed to include confidential, proprietary, and private information for which special protection from public disclosure and from any purpose other than prosecuting this litigation may be warranted. Accordingly, the Parties hereby stipulate to and petition the Court to enter their Stipulated Confidentiality and Protective Order (the “Order”) in this matter. This Order applies equally to CONFIDENTIAL and HIGHLY CONFIDENTIAL material (as defined below) produced/provided and designated as such in this action. The Parties acknowledge that this Order does not confer blanket protections on all disclosures or responses to discovery and that the protection it affords from publish disclosure and use extends only to the limited information or items that are entitled to confidential treatment under the applicable legal principles. The Parties further acknowledge, as set forth in Section IV below, that this Order does not entitle them to file confidential information under seal; Civil Local Rule 79-5 sets forth the procedures that must be followed and the standards that will be applied when a Party seeks permission from the court to file material under seal.

II. Good Cause Statement

This action is likely to involve trade secrets, commercial, financial, and/or proprietary information for which special protection from public disclosure and from use for any purpose other than prosecution of this action is warranted. Such confidential and proprietary materials and information consist of, among other things, confidential business or financial information, information regarding confidential business practices, or other confidential research, development, or commercial information (including information implicating privacy rights of third parties), information otherwise generally unavailable to the public, or which may be privileged or otherwise protected from disclosure under state or federal statutes, court rules, case decisions, or common law. Accordingly, to expedite the flow of information, to facilitate the prompt resolution of disputes over confidentiality of discovery materials, to adequately protect information the Parties are entitled to keep confidential, to ensure that the Parties are permitted reasonable necessary uses of such material in preparation for and in the conduct of trial, to address their handling at the end of the litigation, and serve the ends of justice, a protective order for such information is justified in this matter. It is the intent of the Parties that information will not be designated as confidential for tactical reasons and that nothing be so designated without a good faith belief that it has been maintained in a confidential, non-public manner, and there is good cause why it should not be part of the public record of this case.

III. The Order

A. Stipulation

1. By stipulating to the Order, the Parties have agreed to be bound by its terms and to request its entry by the Court.

B. Discovery Phase

1. For purposes of this Order, the following definitions shall apply: (a) the term “document” and “electronically stored information” shall have the full meanings ascribed to each by the Federal Rules of Civil Procedure and the United States District Court for the Central District of California Local Rules, and relevant case law; and (b) the term “producing Party” shall be defined as any Party or non-party who is required to produce or provide materials or testimony containing confidential information.

2. A producing Party may designate as “CONFIDENTIAL” any material the producing Party believes in good faith constitutes or discloses information that qualifies for protection, including but not limited to, deposition and trial testimony/transcripts and exhibits thereto, and specifically information that is trade secret or other confidential research, development, or commercial information, and materials that are deemed confidential under Federal Drug Administration (“FDA”) regulations and Health Insurance Portability and Accountability Act (“HIPAA”) statutes and/or regulations.

3. Confidential information may be further designated as “HIGHLY CONFIDENTIAL” if Defendants produce materials, including but not limited to, deposition and trial testimony/transcripts and exhibits thereto, that they believe in good faith would, if disclosed, cause substantial economic harm to the competitive position of the entity or entities from which the information was obtained because it is HIGHLY CONFIDENTIAL research and development material on a new product that has not been approved or cleared by the FDA or a similar regulatory body or reflects a Party's price competitiveness in the market or marketing business strategies of a Party concerning a current or new product.

4. Challenges to Designations or Redacted Information: Any Party may at any time that is consistent with the District Judge's scheduling orders challenge the redaction or the designation of information as CONFIDENTIAL or HIGHLY CONFIDENTIAL by providing written notice of its objection to the designating Party, or, in the case of a deposition, either on the record at a deposition or in writing later. Thereafter, counsel for the objecting Party must arrange for a meet and confer conference consistent with Local Rule 37-1. If, after the meet-and-confer process required by Local Rule 37-1, the Parties cannot reach an agreement, the Party claiming the designation of confidentiality or redaction may apply for an appropriate ruling from the Court by following Local Rule 37-2 procedure for Moving Papers, including the filing of a Joint Stipulation, and noticing the hearing of the motion in accordance with Local Rule 37-3. The disputed material shall continue to be treated as designated, or redacted, until the Court orders otherwise. In any such application concerning a ruling on confidentiality or redacted information, the Party claiming the designation of confidentiality or redaction has the burden of establishing that such confidential designation or redaction is proper.

5. No person or Party subject to this Order shall distribute, transmit, or otherwise divulge any material marked CONFIDENTIAL or HIGHLY CONFIDENTIAL, except in accordance with this Order.

6. Use of Confidential Material Limited to this Action: Any document or other material which is marked CONFIDENTIAL or HIGHLY CONFIDENTIAL, or the contents thereof, may be used by a Party, or a Party's attorney (inside counsel or outside counsel), expert witness, consultant, or other person to whom disclosure is made, only for the purpose of this action. Nothing contained in this Order shall prevent the use of any document or the contents thereof, at any deposition taken in this action. If a Party intends to use material that has been marked as HIGHLY CONFIDENTIAL at the deposition of an employee or former employee of a non-producing Party in this litigation, then the Party shall notify the producing Party ten (10) days in advance of the deposition that it intends to use that category of material. If the Parties cannot agree on parameters for usage of the material at the deposition, then the producing Party will seek the direction of the Court as to the utilization of that category of material in the deposition.

7. Access to Confidential Material: If a Party or attorney wishes to disclose any document or other material which is marked CONFIDENTIAL or HIGHLY CONFIDENTIAL, or the contents thereof, to any person actively, or retained to, work on this action (e.g., expert witness, consultant), the person making the disclosure shall do the following:

(a) Provide a copy of this Order to the person to whom disclosure is made;
(b) Inform the person to whom disclosure is made that s/he is bound by this Order;
(c) Require the person to whom disclosure is made to sign an acknowledgment and receipt of this Order;
(d) Instruct the person to whom disclosure is made to return or, in the alternative and with permission of the producing Party, at the conclusion of the case to destroy any document or other material which is marked CONFIDENTIAL or HIGHLY CONFIDENTIAL, including notes or memoranda made from CONFIDENTIAL or HIGHLY CONFIDENTIAL material;
(e) Maintain a list of persons to whom disclosure was made and the CONFIDENTIAL or HIGHLY CONFIDENTIAL materials which were disclosed to that person;
(f) At the conclusion of this action, gather the CONFIDENTIAL or HIGHLY CONFIDENTIAL materials, copies thereof, and related notes and memoranda, and return them to the Party or attorney who originally disclosed them, or destroy them, providing a certificate of compliance with the terms of this Protective Order. If counsel for one Party have created work product incorporating, describing or referring to another Party's confidential or highly confidential documents, counsel who have created the work product must collect all copies from experts and other consultants and must return or destroy all copies of confidential or highly confidential documents attached to the work product. However, the counsel that created the work product may retain the work product itself once all copies are collected and all copies of confidential or highly
confidential documents are returned or destroyed. No. work product incorporating, describing or referring to another Party's confidential or highly confidential documents may be disseminated to any person or used for any purpose once the litigation is concluded.; and
(g) With respect to access or use of HIGHLY CONFIDENTIAL documents by in-house counsel, only “Designated In-House Counsel” of Defendants may have access to information designated as HIGHLY CONFIDENTIAL by another producing Party. “Designated In-House Counsel” shall mean: (1) an in-house attorney; and (2) one paralegal and/or clerical employee for each such Designated In-House Counsel to provide administrative support. Each Designated In-House Counsel shall complete and sign a copy of the Undertaking in Exhibit A, and each such completed, signed form shall be transmitted by e-mail to counsel for the other Parties before disclosure of any such other Party's CONFIDENTIAL or HIGHLY CONFIDENTIAL information to the Designated In-House Counsel.

8. Redaction of CONFIDENTIAL Material: The Parties recognize that certain FDA, other governmental agencies, and certain relevant statutes require redaction of certain information prior to production of certain information by Defendants and that Defendants will comply with those requirements and redact such information as directed. Producing Parties will provide a redaction log identifying the reason for redaction. Any Party challenging information that has been redacted may do so in accordance with Paragraph III.B.4 of this Protective Order, or otherwise in accordance with the Federal Rules of Civil Procedure and the United States District Court for the Central District of California Local Rules and/or Orders of this Court.

9. Use of CONFIDENTIAL Material at Depositions: All transcripts and exhibits shall be treated as if designated CONFIDENTIAL for a period of thirty (30) days after the transcript is available from the court reporter. Counsel for any Party may designate during the deposition or during the thirty day period after the transcript is available from the court reporter any portion of the transcript as CONFIDENTIAL or HIGHLY CONFIDENTIAL by denominating by page and line, and by designating any exhibits, that are to be considered CONFIDENTIAL or HIGHLY CONFIDENTIAL pursuant to the criteria set forth in this Order. Such designation shall be communicated to all Parties. Transcript portions and exhibits designated in accordance with this paragraph shall be disclosed only in accordance with this Order. A Party may challenge the CONFIDENTIAL or HIGHLY CONFIDENTIAL designation or portions thereof in accordance with the provisions of Paragraph III.B.4 above.

10. Inadvertent Failure to Properly Designate CONFIDENTIAL Material: Inadvertent production of any document or information without a designation of CONFIDENTIAL or HIGHLY CONFIDENTIAL will not be deemed to waive a Party's claim to its CONFIDENTIAL nature or stop said Party from designating said document or information as CONFIDENTIAL or HIGHLY CONFIDENTIAL at a later date. Disclosure of said document or information by another Party prior to such later designation shall not be deemed a violation of the provisions of this Order.

11. Inadvertent Disclosure of Privileged Documents, “Clawback” Procedure: Inadvertent production of documents or electronically stored information (“ESI”) (collectively “Inadvertently Produced Documents”) subject to work-product or attorney-client privilege, or other legal privilege protecting information from discovery, shall not constitute a waiver of the privilege, provided that the producing Party shall notify the receiving Party in writing as set forth herein. In the event that a Party inadvertently produces documents or ESI subject to a claim of privilege, the producing Party shall, within ten (10) days of the discovery of the inadvertent disclosure, notify the other Party in writing of the inadvertent disclosure. The producing Party may, in the notice, request a “clawback” of the inadvertently disclosed material. The obligations of the receiving Party are those set forth in Federal Rule of Civil Procedure 26(b)(5)(B).

If the receiving Party elects to file a motion as set forth below, the receiving Party, subject to the requirements below, may retain possession of the Inadvertently Produced Documents as well as any notes or other work product of the receiving Party reflecting the contents of such materials pending the resolution by the Court of the motion below, but shall segregate and not use them pending resolution of the motion. If the receiving Party's motion is denied, the receiving Party shall promptly comply with the immediately preceding provisions of this paragraph. No. use shall be made of such Inadvertently Produced Documents during depositions or at trial, nor shall they be disclosed to anyone who was not given access to them prior to the request to return or destroy them unless otherwise ordered by the Court.

The Party receiving such Inadvertently Produced Documents may, after receipt of the producing Party's notice of inadvertent production, move the Court to dispute the claim of privilege.

12. There is no waiver of privilege or work product protection in this matter or any other matter in any other jurisdiction for any document clawed-back under this clause, or for the subject matter of any such document, whether the privileged document was inadvertently provided following review or as part of a “Quick Peek” production. Nothing in this Order is intended to displace or substitute the Federal Rules of Civil Procedure applicable to inadvertent disclosures.

13. Disclosure/Production of Documents, No. Waiver: A Party's disclosure or production of any document or group or category of documents (the “produced documents”) shall not constitute a waiver of any privilege or protection, including but not limited to privilege or work product protection with respect to: (a) any other communications or documents relating or referring to the same or similar subject matter (“subject matter waiver”); and (b) any other communications or documents referring or relating to the Parties who sent or received or are named in any such document or documents. A Party thus may not challenge another Party's claims of privilege for documents remaining on its privilege logs on grounds of waiver of any privilege or protection.

C. POST DISCOVERY PHASE

1. Trial: Any use of protected material at trial or other court hearings or proceedings shall be governed by the orders of the trial judge.

2. Survival of Protective Order: Throughout and after the conclusion of this litigation, including any appeals, the restrictions on communication and disclosure provided for herein shall continue to be binding upon the Parties and all other persons to whom CONFIDENTIAL and HIGHLY CONFIDENTIAL material has been communicated or disclosed pursuant to the provisions of this Order or any other order of the Court.

3. Return or Destruction of CONFIDENTIAL Material Upon Termination of Litigation: Within sixty (60) days after the final termination of this action, each Party, upon request of the other Party, shall either return to the producing Party, or destroy, all CONFIDENTIAL and HIGHLY CONFIDENTIAL material designated by any other Party (including any such material disclosed to third persons), except for any attorneys' work-product for the Party returning the material, and shall provide confirmation in writing to opposing counsel if such materials are destroyed.

4. Modification of this Order: Nothing in this Order shall prevent any other Party from seeking amendments broadening or restricting the rights of access to or the use of CONFIDENTIAL and/or HIGHLY CONFIDENTIAL material or otherwise modifying this Order; and this Order may be amended without leave of the Court by the agreement of the undersigned attorneys for the Parties in the form of a Stipulation that shall be filed in this case.

IV. MISCELLANEOUS

1. This Order does not apply to the Court and court personnel, who are subject only to the court's internal procedures regarding the handling of material filed or lodged, including material filed or lodged under seal.

2. A Party that seeks to file under seal any documents designated CONFIDENTIAL or HIGHLY CONFIDENTIAL must comply with Civil Local Rule 79-5. Documents designated CONFIDENTIAL or HIGHLY CONFIDENTIAL may only be filed under seal pursuant to a court order authorizing the sealing of the specific documents at issue. If a Party's request to file CONFIDENTIAL or HIGHLY CONFIDENTIAL documents under seal is denied by the court, then the receiving Party may file the information in the public record unless otherwise instructed by the court.

3. Nothing in the Order shall be construed as authorizing or encouraging a Party to disobey a lawful subpoena or court order issued in another action.

IT IS SO ORDERED.

EXHIBIT A ACKNOWLEDGMENT AND AGREEMENT TO BE BOUND

I, ___ [print or type full name], of ___ [print or type full address], declare under penalty of perjury that I have read in its entirety and understand the Stipulated Protective Order that was issued by the United States District Court for the Central District of California on ___ in the case of Audra McDonald v. American Medical Systems, Inc., et al., United States District Court, Central District of California, Case No. 2:21-cv-09649-MCS-PD. I agree to comply with and to be bound by all the terms of this Stipulated Confidentially and Protective Order and I understand and acknowledge that failure to so comply could expose me to sanctions and punishment in the nature of contempt. I solemnly promise that I will not disclose in any manner any information or item that is subject to this Stipulated Confidentiality and Protective Order to any person or entity except in strict compliance with the provisions of this Order. I further agree to submit to the jurisdiction of the United States District Court for the Central District of California for enforcing the terms of this Stipulated Confidentiality and Protective Order, even if such enforcement proceedings occur after termination of this action. I hereby appoint ___ [print or type full name] of ___ [print or type full address and telephone number] as my California agent for service of process in connection with this action or any proceedings related to enforcement of this Stipulated Confidentiality and Protective Order.


Summaries of

McDonald v. Am. Med. Sys.

United States District Court, Central District of California
Mar 22, 2022
2:21-cv-09649-MCS-PD (C.D. Cal. Mar. 22, 2022)
Case details for

McDonald v. Am. Med. Sys.

Case Details

Full title:AUDRA MCDONALD, Plaintiff, v. AMERICAN MEDICAL SYSTEMS, INC.; and DOES…

Court:United States District Court, Central District of California

Date published: Mar 22, 2022

Citations

2:21-cv-09649-MCS-PD (C.D. Cal. Mar. 22, 2022)